nach oben

International Ophthalmology

Erschienen in:

20.04.2020 | COVID-19 Zur Zeit gratis

COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights

verfasst von: Piergiorgio Neri, Francesco Pichi

Erschienen in: International Ophthalmology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Excerpt

Corona virus represents nowadays the hot topic in the scientific world due to the outbreak of a novel serotype formerly named coronavirus disease (COVID)-19 and now identified as severe acute respiratory syndrome (SARS)-COV-2 [1]. …

Seah I, Agarwal R (2019) Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm 28(3):391–395CrossRef

WHO (2020) WHO director-general’s opening remarks at the media briefing on COVID-19—11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed 11 April 2020

WHO (2020) Coronavirus disease 2019 (COVID-19) situation report—81. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200410-sitrep-81-covid-19.pdf?sfvrsn=ca96eb84_2. Accessed 11 April 2020

Colson P, Rolain JM, Lagier JC et al (2020) Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105932 CrossRefPubMedPubMedCentral

Sohrabi C, Alsafi Z, O’Neill N et al (2020) World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 76:71–76CrossRef

Mehta P, McAuley DF, Brown M et al (2020) HLH across speciality collaboration, UK COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034. https://doi.org/10.1016/s0140-6736(20)30628-0 CrossRefPubMed

Zhang C, Wu Z, Li JW et al (2020) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105954 CrossRefPubMedPubMedCentral

Robbins SG, Detrick B, Hooks JJ (1990) Retinopathy following intravitreal injection of mice with MHV strain JHM. Adv Exp Med Biol 276:519–524. https://doi.org/10.1007/978-1-4684-5823-7_72 CrossRefPubMed

Robbins SG, Detrick B, Hooks JJ (1991) Ocular tropisms of murine coronavirus (strain JHM) after inoculation by various routes. Invest Ophthalmol Vis Sci 32(6):1883–1893PubMed

10.

Zhao H, Shen D, Zhou H et al (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol [Online ahead of print]

11.

Yao XH, Li TY, He ZC et al (2020) A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi 49:E009 (in Chinese) PubMed

12.

Hooper LC, Chin MS, Detrick B, Hooks JJ (2005) Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling. J Neuroimmunol 166(1–2):65–74CrossRef

13.

Fischer A, Antoniou KM, Brown KK et al (2015) “ERS/ATS task force on undifferentiated forms of CTD-ILD”. An official European respiratory society/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976–987CrossRef

14.

Xu J, Tan DY, Fu YY et al (2015) Do corticosteroids have a role in treating Ebola virus disease? Sci China Life Sci 58(1):111–113CrossRef

15.

Shang L, Zhao J, Hu Y et al (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395(10225):683–684CrossRef

16.

Stahl JP, Mailles A (2019) Herpes simplex virus encephalitis update. Curr Opin Infect Dis 32(3):239–243CrossRef

17.

Chaudhuri A, Kennedy PGE (2002) Diagnosis and treatment of viral encephalitis. Postgrad Med J 78:575–583CrossRef

18.

Smits SL, de Lang A, van den Brand JMA et al (2010) Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog 6(2):e1000756CrossRef

Titel: COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights
verfasst von: Piergiorgio Neri
Francesco Pichi
Publikationsdatum: 20.04.2020
Verlag: Springer Netherlands
Schlagwort: COVID-19
Erschienen in: International Ophthalmology / Ausgabe 5/2020
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-020-01389-2

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights

Excerpt

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Paracentesis as valve re-bubbling technique for Descemet’s membrane endothelial keratoplasty (DMEK) graft detachment

Does TRABECULECTOMY meet the 10-10-10 challenge in PACG, POAG, JOAG and Secondary glaucomas?

Multimodal imaging patterns of posterior syphilitic uveitis: a review of the literature, laboratory evaluation and treatment

Outcome and risk of ocular complications of managing children with chronic anterior uveitis with topical rimexolone 1%

Assessment of peripapillary vessel density in acute non-arteritic anterior ischemic optic neuropathy

A study of dry eye after cataract surgery in MGD patients

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde